In the absence of explicit annotation of disease severity, the lack of any elevated CH prevalence by genotype, especially for Hb SS which is typically more severe, suggests that there is little impact of disease severity on CH prevalence. Here, GSTM1 is linked to cyclic hematopoiesis.